Cite
HARVARD Citation
Cote, G. et al. (2020). A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas. European journal of cancer. pp. 21-32. [Online].